This report studies and analyses global Prostate Cancer Hormone Therapy status and future trends, to help determine the Prostate Cancer Hormone Therapy market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Prostate Cancer Hormone Therapy, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Prostate Cancer Hormone Therapy market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Prostate Cancer Hormone Therapy by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Prostate Cancer Hormone Therapy by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Prostate Cancer Hormone Therapy key consuming regions, consumption value and demand structure
(5) Prostate Cancer Hormone Therapy industry chains, upstream, midstream and downstream
According to YH Research, the global market for Prostate Cancer Hormone Therapy should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China Prostate Cancer Hormone Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Prostate Cancer Hormone Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Market segment by players, this report covers
Pfizer
Astellas
Johnson & Johnson
AstraZeneca
Bayer
Merck
Tolmar
Zoladex
Ferring Pharmaceuticals
Jiangsu Hengrui Pharmaceuticals
CTTQ
Market segment by Type, covers
Tablet
Injection
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Prostate Cancer Hormone Therapy product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Prostate Cancer Hormone Therapy market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Prostate Cancer Hormone Therapy market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Prostate Cancer Hormone Therapy industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Prostate Cancer Hormone Therapy Definition
1.2 Global Prostate Cancer Hormone Therapy Market Size and Forecast
1.3 China Prostate Cancer Hormone Therapy Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Prostate Cancer Hormone Therapy Market Size: China VS Global Growth Rate, 2018-2029
1.6 Prostate Cancer Hormone Therapy Market Dynamics
1.6.1 Prostate Cancer Hormone Therapy Market Drivers
1.6.2 Prostate Cancer Hormone Therapy Market Restraints
1.6.3 Prostate Cancer Hormone Therapy Industry Trends
1.6.4 Prostate Cancer Hormone Therapy Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Prostate Cancer Hormone Therapy, Global Market Share by Company, 2018-2023
2.2 Global Prostate Cancer Hormone Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Prostate Cancer Hormone Therapy Concentration Ratio
2.4 Global Prostate Cancer Hormone Therapy Mergers & Acquisitions, Expansion Plans
2.5 Global Prostate Cancer Hormone Therapy Major Companies Product Type
2.6 Head Office and Prostate Cancer Hormone Therapy Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Prostate Cancer Hormone Therapy, China Market Share by Company, 2018-2023
3.2 China Prostate Cancer Hormone Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Prostate Cancer Hormone Therapy Industry Chain
4.2 Prostate Cancer Hormone Therapy Upstream Analysis
4.2.1 Prostate Cancer Hormone Therapy Core Raw Materials
4.2.2 Main Manufacturers of Prostate Cancer Hormone Therapy Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Prostate Cancer Hormone Therapy Production Mode
4.6 Prostate Cancer Hormone Therapy Procurement Model
4.7 Prostate Cancer Hormone Therapy Industry Sales Model and Sales Channels
4.7.1 Prostate Cancer Hormone Therapy Sales Model
4.7.2 Prostate Cancer Hormone Therapy Typical Distributors
5 Sights by Type
5.1 Prostate Cancer Hormone Therapy Classification
5.1.1 Tablet
5.1.2 Injection
5.2 By Type, Global Prostate Cancer Hormone Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Prostate Cancer Hormone Therapy Consumption Value, 2018-2029
6 Sights by Application
6.1 Prostate Cancer Hormone Therapy Segment by Application
6.1.1 Hospital
6.1.2 Clinic
6.1.3 Others
6.2 By Application, Global Prostate Cancer Hormone Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Prostate Cancer Hormone Therapy Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Prostate Cancer Hormone Therapy Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Prostate Cancer Hormone Therapy Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Prostate Cancer Hormone Therapy & Forecasts, 2018-2029
7.3.2 By Country, North America Prostate Cancer Hormone Therapy Market Size Market Share
7.4 Europe
7.4.1 Europe Prostate Cancer Hormone Therapy Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Prostate Cancer Hormone Therapy Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Prostate Cancer Hormone Therapy Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Prostate Cancer Hormone Therapy Market Size Market Share
7.6 South America
7.6.1 South America Prostate Cancer Hormone Therapy Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Prostate Cancer Hormone Therapy Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Prostate Cancer Hormone Therapy Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Prostate Cancer Hormone Therapy Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Prostate Cancer Hormone Therapy Market Size, 2018-2029
8.3.2 By Type, U.S. Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Prostate Cancer Hormone Therapy Market Size, 2018-2029
8.4.2 By Type, Europe Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Prostate Cancer Hormone Therapy Market Size, 2018-2029
8.5.2 By Type, China Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Prostate Cancer Hormone Therapy Market Size, 2018-2029
8.6.2 By Type, Japan Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Prostate Cancer Hormone Therapy Market Size, 2018-2029
8.7.2 By Type, South Korea Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Prostate Cancer Hormone Therapy Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Prostate Cancer Hormone Therapy Market Size, 2018-2029
8.9.2 By Type, India Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Prostate Cancer Hormone Therapy Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Pfizer
9.1.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.1.2 Pfizer Company Profile and Main Business
9.1.3 Pfizer Prostate Cancer Hormone Therapy Models, Specifications and Application
9.1.4 Pfizer Prostate Cancer Hormone Therapy Revenue and Gross Margin, 2018-2023
9.1.5 Pfizer Recent Developments
9.2 Astellas
9.2.1 Astellas Company Information, Head Office, Market Area and Industry Position
9.2.2 Astellas Company Profile and Main Business
9.2.3 Astellas Prostate Cancer Hormone Therapy Models, Specifications and Application
9.2.4 Astellas Prostate Cancer Hormone Therapy Revenue and Gross Margin, 2018-2023
9.2.5 Astellas Recent Developments
9.3 Johnson & Johnson
9.3.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.3.2 Johnson & Johnson Company Profile and Main Business
9.3.3 Johnson & Johnson Prostate Cancer Hormone Therapy Models, Specifications and Application
9.3.4 Johnson & Johnson Prostate Cancer Hormone Therapy Revenue and Gross Margin, 2018-2023
9.3.5 Johnson & Johnson Recent Developments
9.4 AstraZeneca
9.4.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
9.4.2 AstraZeneca Company Profile and Main Business
9.4.3 AstraZeneca Prostate Cancer Hormone Therapy Models, Specifications and Application
9.4.4 AstraZeneca Prostate Cancer Hormone Therapy Revenue and Gross Margin, 2018-2023
9.4.5 AstraZeneca Recent Developments
9.5 Bayer
9.5.1 Bayer Company Information, Head Office, Market Area and Industry Position
9.5.2 Bayer Company Profile and Main Business
9.5.3 Bayer Prostate Cancer Hormone Therapy Models, Specifications and Application
9.5.4 Bayer Prostate Cancer Hormone Therapy Revenue and Gross Margin, 2018-2023
9.5.5 Bayer Recent Developments
9.6 Merck
9.6.1 Merck Company Information, Head Office, Market Area and Industry Position
9.6.2 Merck Company Profile and Main Business
9.6.3 Merck Prostate Cancer Hormone Therapy Models, Specifications and Application
9.6.4 Merck Prostate Cancer Hormone Therapy Revenue and Gross Margin, 2018-2023
9.6.5 Merck Recent Developments
9.7 Tolmar
9.7.1 Tolmar Company Information, Head Office, Market Area and Industry Position
9.7.2 Tolmar Company Profile and Main Business
9.7.3 Tolmar Prostate Cancer Hormone Therapy Models, Specifications and Application
9.7.4 Tolmar Prostate Cancer Hormone Therapy Revenue and Gross Margin, 2018-2023
9.7.5 Tolmar Recent Developments
9.8 Zoladex
9.8.1 Zoladex Company Information, Head Office, Market Area and Industry Position
9.8.2 Zoladex Company Profile and Main Business
9.8.3 Zoladex Prostate Cancer Hormone Therapy Models, Specifications and Application
9.8.4 Zoladex Prostate Cancer Hormone Therapy Revenue and Gross Margin, 2018-2023
9.8.5 Zoladex Recent Developments
9.9 Ferring Pharmaceuticals
9.9.1 Ferring Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.9.2 Ferring Pharmaceuticals Company Profile and Main Business
9.9.3 Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Models, Specifications and Application
9.9.4 Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Revenue and Gross Margin, 2018-2023
9.9.5 Ferring Pharmaceuticals Recent Developments
9.10 Jiangsu Hengrui Pharmaceuticals
9.10.1 Jiangsu Hengrui Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.10.2 Jiangsu Hengrui Pharmaceuticals Company Profile and Main Business
9.10.3 Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Models, Specifications and Application
9.10.4 Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Revenue and Gross Margin, 2018-2023
9.10.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
9.11 CTTQ
9.11.1 CTTQ Company Information, Head Office, Market Area and Industry Position
9.11.2 CTTQ Company Profile and Main Business
9.11.3 CTTQ Prostate Cancer Hormone Therapy Models, Specifications and Application
9.11.4 CTTQ Prostate Cancer Hormone Therapy Revenue and Gross Margin, 2018-2023
9.11.5 CTTQ Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. Prostate Cancer Hormone Therapy Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Prostate Cancer Hormone Therapy Market Restraints
Table 3. Prostate Cancer Hormone Therapy Market Trends
Table 4. Prostate Cancer Hormone Therapy Industry Policy
Table 5. Global Prostate Cancer Hormone Therapy Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Prostate Cancer Hormone Therapy Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Prostate Cancer Hormone Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Prostate Cancer Hormone Therapy Mergers & Acquisitions, Expansion Plans
Table 9. Global Prostate Cancer Hormone Therapy Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Prostate Cancer Hormone Therapy Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Prostate Cancer Hormone Therapy Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Prostate Cancer Hormone Therapy Upstream (Raw Materials)
Table 14. Global Prostate Cancer Hormone Therapy Typical Customers
Table 15. Prostate Cancer Hormone Therapy Typical Distributors
Table 16. By Type, Global Prostate Cancer Hormone Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Prostate Cancer Hormone Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Prostate Cancer Hormone Therapy Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Prostate Cancer Hormone Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Prostate Cancer Hormone Therapy Consumption Value Market Share, 2018-2029
Table 23. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 24. Pfizer Company Profile and Main Business
Table 25. Pfizer Prostate Cancer Hormone Therapy Models, Specifications, and Application
Table 26. Pfizer Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Pfizer Recent Developments
Table 28. Astellas Company Information, Head Office, Market Area and Industry Position
Table 29. Astellas Company Profile and Main Business
Table 30. Astellas Prostate Cancer Hormone Therapy Models, Specifications, and Application
Table 31. Astellas Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Astellas Recent Developments
Table 33. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 34. Johnson & Johnson Company Profile and Main Business
Table 35. Johnson & Johnson Prostate Cancer Hormone Therapy Models, Specifications, and Application
Table 36. Johnson & Johnson Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Johnson & Johnson Recent Developments
Table 38. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 39. AstraZeneca Company Profile and Main Business
Table 40. AstraZeneca Prostate Cancer Hormone Therapy Models, Specifications, and Application
Table 41. AstraZeneca Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. AstraZeneca Recent Developments
Table 43. Bayer Company Information, Head Office, Market Area and Industry Position
Table 44. Bayer Company Profile and Main Business
Table 45. Bayer Prostate Cancer Hormone Therapy Models, Specifications, and Application
Table 46. Bayer Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Bayer Recent Developments
Table 48. Merck Company Information, Head Office, Market Area and Industry Position
Table 49. Merck Company Profile and Main Business
Table 50. Merck Prostate Cancer Hormone Therapy Models, Specifications, and Application
Table 51. Merck Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Merck Recent Developments
Table 53. Tolmar Company Information, Head Office, Market Area and Industry Position
Table 54. Tolmar Company Profile and Main Business
Table 55. Tolmar Prostate Cancer Hormone Therapy Models, Specifications, and Application
Table 56. Tolmar Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Tolmar Recent Developments
Table 58. Zoladex Company Information, Head Office, Market Area and Industry Position
Table 59. Zoladex Company Profile and Main Business
Table 60. Zoladex Prostate Cancer Hormone Therapy Models, Specifications, and Application
Table 61. Zoladex Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Zoladex Recent Developments
Table 63. Ferring Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 64. Ferring Pharmaceuticals Company Profile and Main Business
Table 65. Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Models, Specifications, and Application
Table 66. Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Ferring Pharmaceuticals Recent Developments
Table 68. Jiangsu Hengrui Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 69. Jiangsu Hengrui Pharmaceuticals Company Profile and Main Business
Table 70. Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Models, Specifications, and Application
Table 71. Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 73. CTTQ Company Information, Head Office, Market Area and Industry Position
Table 74. CTTQ Company Profile and Main Business
Table 75. CTTQ Prostate Cancer Hormone Therapy Models, Specifications, and Application
Table 76. CTTQ Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. CTTQ Recent Developments
List of Figures
Figure 1. Prostate Cancer Hormone Therapy Picture
Figure 2. Global Prostate Cancer Hormone Therapy Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Prostate Cancer Hormone Therapy Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Prostate Cancer Hormone Therapy Market Share of Global, 2018-2029
Figure 5. Global Prostate Cancer Hormone Therapy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Prostate Cancer Hormone Therapy Key Participants, Market Share, 2022
Figure 7. Prostate Cancer Hormone Therapy Industry Chain
Figure 8. Prostate Cancer Hormone Therapy Procurement Model
Figure 9. Prostate Cancer Hormone Therapy Sales Model
Figure 10. Prostate Cancer Hormone Therapy Sales Channels, Direct Sales, and Distribution
Figure 11. Tablet
Figure 12. Injection
Figure 13. By Type, Global Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million
Figure 14. By Type, Global Prostate Cancer Hormone Therapy Consumption Value Market Share, 2018-2029
Figure 15. Hospital
Figure 16. Clinic
Figure 17. Others
Figure 18. By Application, Global Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million
Figure 19. By Application, Global Prostate Cancer Hormone Therapy Consumption Value Market Share, 2018-2029
Figure 20. By Region, Global Prostate Cancer Hormone Therapy Consumption Value Market Share, 2018-2029
Figure 21. North America Prostate Cancer Hormone Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022
Figure 23. Europe Prostate Cancer Hormone Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022
Figure 25. Asia Pacific Prostate Cancer Hormone Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022
Figure 27. South America Prostate Cancer Hormone Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022
Figure 29. Middle East & Africa Prostate Cancer Hormone Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million
Figure 31. By Type, U.S. Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 32. By Application, U.S. Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 33. Europe Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million
Figure 34. By Type, Europe Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 35. By Application, Europe Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 36. China Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million
Figure 37. By Type, China Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 38. By Application, China Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 39. Japan Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million
Figure 40. By Type, Japan Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 41. By Application, Japan Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 42. South Korea Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million
Figure 43. By Type, South Korea Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 44. By Application, South Korea Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 45. Southeast Asia Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million
Figure 46. By Type, Southeast Asia Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 47. By Application, Southeast Asia Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 48. India Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million
Figure 49. By Type, India Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 50. By Application, India Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 51. Middle East & Africa Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million
Figure 52. By Type, Middle East & Africa Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 53. By Application, Middle East & Africa Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029
Figure 54. Research Methodology
Figure 55. Breakdown of Primary Interviews
Figure 56. Bottom-up and Top-down Approaches
Figure 57. Top-down Approaches
Reason to Buy